These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34900210)

  • 1. Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis.
    Ferrucci S; Romagnuolo M; Maronese CA; Germiniasi F; Tavecchio S; Angileri L; Casazza G; Marzano AV; Genovese G
    Ther Adv Chronic Dis; 2021; 12():20406223211058332. PubMed ID: 34900210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study.
    Montero-Vilchez T; Rodriguez-Pozo JA; Diaz-Calvillo P; Salazar-Nievas M; Tercedor-Sanchez J; Molina-Leyva A; Arias-Santiago S
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instrumental evaluation of skin barrier function and clinical outcomes during dupilumab treatment for atopic dermatitis: An observational study.
    Cristaudo A; Pigliacelli F; Sperati F; Orsini D; Cameli N; Morrone A; Mariano M
    Skin Res Technol; 2021 Sep; 27(5):810-813. PubMed ID: 33651467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis.
    Berdyshev E; Goleva E; Bissonnette R; Bronova I; Bronoff AS; Richers BN; Garcia S; Ramirez-Gama M; Taylor P; Praestgaard A; Agueusop I; Jurvilliers P; Boguniewicz M; Levit NA; Rossi AB; Zhang A; Leung DYM
    Allergy; 2022 Nov; 77(11):3388-3397. PubMed ID: 35815904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
    Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR
    N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis.
    Lee SJ; Kim SE; Shin KO; Park K; Lee SE
    Allergy Asthma Immunol Res; 2021 Sep; 13(5):762-775. PubMed ID: 34486260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience.
    Ferrucci S; Casazza G; Angileri L; Tavecchio S; Germiniasi F; Berti E; Marzano AV; Genovese G
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32183179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratum Corneum Hydration As a Potential Marker of Response to Dupilumab in Atopic Dermatitis®: A Prospective Observational Study.
    Montero-Vilchez T; Rodriguez-Pozo JA; Cuenca-Barrales C; Sanabria-de-la-Torre R; Torres-de-Pinedo JM; Arias-Santiago S
    Dermatitis; 2024; 35(3):250-257. PubMed ID: 37695812
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of dupilumab on skin barrier function: A systematic review.
    Montero-Vilchez T; Sanabria-de-la-Torre R; Sanchez-Diaz M; Ureña-Paniego C; Molina-Leyva A; Arias-Santiago S
    J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1284-1292. PubMed ID: 36995919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
    Fargnoli MC; Esposito M; Ferrucci S; Girolomoni G; Offidani A; Patrizi A; Peris K; Costanzo A; Malara G; Pellacani G; Romanelli M; Amerio P; Cristaudo A; Flori ML; Motolese A; Betto P; Patruno C; Pigatto P; Sirna R; Stinco G; Zalaudek I; Bianchi L; Boccaletti V; Cannavò SP; Cusano F; Lembo S; Mozzillo R; Gallo R; Potenza C; Rongioletti F; Tiberio R; Grieco T; Micali G; Persechino S; Pettinato M; Pucci S; Savi E; Stingeni L; Romano A; Argenziano G;
    J Dermatolog Treat; 2021 Aug; 32(5):507-513. PubMed ID: 31647347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment.
    Dini V; Iannone M; Michelucci A; Manzo Margiotta F; Granieri G; Salvia G; Oranges T; Janowska A; Morganti R; Romanelli M
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients.
    Shan J; Ali K; Da J; Li M; Qiu Y; Lou H; Wu L
    Clin Cosmet Investig Dermatol; 2022; 15():2437-2443. PubMed ID: 36387959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microscopic and functional changes observed with dynamic optical coherence tomography for severe refractory atopic dermatitis treated with dupilumab.
    Manfredini M; Liberati S; Ciardo S; Bonzano L; Guanti M; Chester J; Kaleci S; Pellacani G
    Skin Res Technol; 2020 Nov; 26(6):779-787. PubMed ID: 32207198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.
    Kelleher M; Dunn-Galvin A; Hourihane JO; Murray D; Campbell LE; McLean WHI; Irvine AD
    J Allergy Clin Immunol; 2015 Apr; 135(4):930-935.e1. PubMed ID: 25618747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
    Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
    J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic.
    Tánczosová M; Kojanová M; Arenbergerová M; Arenberger P; Doležal T; Štrosová D; Fialová J; Gkalpakiotis S
    Cent Eur J Public Health; 2022 Mar; 30(1):46-50. PubMed ID: 35421298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
    Takeuchi S; Inoue K; Kuretake K; Kiyomatsu-Oda M; Furue M
    J Dermatol; 2021 May; 48(5):638-644. PubMed ID: 33742710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab for the treatment of adolescents with atopic dermatitis.
    Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
    Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study.
    Patruno C; Napolitano M; Argenziano G; Peris K; Ortoncelli M; Girolomoni G; Offidani A; Ferrucci SM; Amoruso GF; Rossi M; Stingeni L; Malara G; Grieco T; Foti C; Gattoni M; Loi C; Iannone M; Talamonti M; Stinco G; Rongioletti F; Pigatto PD; Cristaudo A; Nettis E; Corazza M; Guarneri F; Amerio P; Esposito M; Belloni Fortina A; Potenza C; Fabbrocini G;
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):958-964. PubMed ID: 33332697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.